久吾高科(300631.SZ):“久吾轉債”可能滿足贖回條件
格隆匯9月7日丨久吾高科(300631.SZ)公佈,公司已決定自2021年8月13日至2021年9月11日期間,如公司股價觸發“久吾轉債”的贖回條款將不行使提前贖回權,不提前贖回“久吾轉債”。上述不贖回期間屆滿後的次一交易日(2021年9月13日)可能會觸發“久吾轉債”的有條件贖回條款。
如後續“久吾轉債”滿足贖回條件後,公司決定行使贖回權的,贖回價格僅為按照以債券面值(人民幣100元)加當期應計利息的價格(含税),與當前“久吾轉債”市場價格差距較大,敬請廣大投資者及時關注公司公吿,注意“久吾轉債”投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.